Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients

Int J Mol Sci. 2019 Jan 28;20(3):546. doi: 10.3390/ijms20030546.

Abstract

Infection with cytomegalovirus (CMV) remains a major problem in kidney transplant recipients, resulting in serious infectious complications and occasionally mortality. Accumulating evidence indicates that natural killer cell immunoglobulin-like receptors (KIRs) and their ligands affect the susceptibility to various diseases, including viral infections (e.g., CMV infection). We investigated whether KIR genes and their ligands affect the occurrence of CMV infection in a group of 138 kidney transplant recipients who were observed for 720 days posttransplantation. We typed the recipients for the presence of KIR genes (human leukocyte antigen C1 [HLA-C1], HLA-C2, HLA-A, HLA-B, and HLA-DR1) by polymerase chain reaction with sequence-specific primers. The multivariate analysis revealed that the lack of KIR2DS2 (p = 0.035), the presence of KIR2DL3 (p = 0.075), and the presence of KIR2DL2⁻HLA-C1 (p = 0.044) were risk factors for posttransplant CMV infection. We also found that a lower estimated glomerular filtration rate (p = 0.036), an earlier time of antiviral prophylaxis initiation (p = 0.025), lymphocytopenia (p = 0.012), and pretransplant serostatus (donor-positive/recipient-negative; p = 0.042) were independent risk factors for posttransplant CMV infection. In conclusion, our findings confirm that the KIR/HLA genotype plays a significant role in anti-CMV immunity and suggest the contribution of both environmental and genetic factors to the incidence of CMV infection after kidney transplantation.

Keywords: cytomegalovirus; human leukocyte antigen; kidney transplantation; killer-cell immunoglobulin-like receptor; lymphocytopenia; natural killer cell.

MeSH terms

  • Adult
  • Aged
  • Cytomegalovirus Infections / genetics*
  • Female
  • Gene Frequency
  • Genetic Markers
  • Genotype
  • HLA-C Antigens / metabolism*
  • Haplotypes / genetics
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Transplantation*
  • Male
  • Middle Aged
  • Receptors, KIR / metabolism*
  • Risk Factors
  • Young Adult

Substances

  • Genetic Markers
  • HLA-C Antigens
  • Receptors, KIR